Skip to main content
Alvotech Holdings S.A logo

Alvotech Holdings S.A — Investor Relations & Filings

Ticker · ALVO ISIN · LU2458332611 LEI · 222100DCZBOWV5DZ8372 LU Manufacturing
Open in API
Filings indexed 913 across all filing types
Latest filing 2026-04-01 Director's Dealing
Country LU Luxembourg
Listing LU ALVO

About Alvotech Holdings S.A

https://www.alvotech.com/

Alvotech is a biotechnology company that specializes in the development and manufacturing of biosimilar medicines for patients worldwide. The company's mission is to improve lives by expanding access to high-quality, affordable biologic medicines. Alvotech operates a fully integrated, end-to-end platform that encompasses the entire process from cell line development through to fill and finish manufacturing. This vertically integrated approach provides control over scale, speed, and quality. For commercialization and registration in global markets, Alvotech leverages strategic partnerships, allowing it to maintain a singular focus on its core development and manufacturing expertise. The company's product pipeline targets various therapeutic areas, including autoimmune and eye disorders.

Recent filings

Filing Released Lang Actions
d
Director's Dealing Classification · 1% confidence The document is a regulatory notification under the CSSF HOS-2 form detailing share acquisitions by a person closely associated with a board member, including transaction date, volume, price, and instrument identification. This matches the insider trading disclosures of directors or persons discharging managerial responsibilities. According to the taxonomy, this is classified as Director’s Dealing (DIRS).
2026-04-01 English
Alvotech birtir ársreikning á eyðublaði 20-F
Report Publication Announcement Classification · 1% confidence The document is a brief press release (3,366 characters) announcing that Alvotech has published its full annual report for fiscal year 2025 on SEC Form 20-F and providing links to the SEC and investor websites. It does not contain the report’s financial contents but simply notifies stakeholders that the report is available. Under the “menu vs. meal” rule for short notices announcing publication of a report, this is classified as a Report Publication Announcement.
2026-03-31 Icelandic
Alvotech files Annual Report with the SEC
Report Publication Announcement Classification · 1% confidence The document is a brief press release (≈4,127 characters) announcing that Alvotech has filed its Annual Report 2025 on Form 20-F with the SEC and provides a link to the full report. It does not contain the report content itself but merely announces its publication. Under the “menu vs. meal” rule, this is a report publication announcement, not the report itself.
2026-03-31 English
Alvotech birtir ársskýrslu fyrir árið 2025
Report Publication Announcement Classification · 1% confidence The document is an announcement stating that Alvotech has published its Annual Report for 2025, providing links to download the PDF and iXBRL files and offering a brief company description. It does not itself contain the full report but directs readers to the report’s availability. Per the “menu vs meal” rule, this is a Report Publication Announcement (RPA).
2026-03-31 Icelandic
Alvotech Publishes 2025 Annual Report
Report Publication Announcement Classification · 1% confidence The document is a short press release (under 5,000 characters) announcing that Alvotech has published its 2025 Annual Report, providing a link and stating the report is attached. It does not contain the report content itself but merely announces its availability. Under the “Menu vs Meal” rule, this is a Report Publication Announcement.
2026-03-31 English
6-K - Alvotech (0001898416) (Filer)
Foreign Filer Report
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.